Terms: = Prostate cancer AND HER1, YOR227W AND Prognosis
3 results:
1. 4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications.
Armengol G; Rojo F; Castellví J; Iglesias C; Cuatrecasas M; Pons B; Baselga J; Ramón y Cajal S
Cancer Res; 2007 Aug; 67(16):7551-5. PubMed ID: 17699757
[TBL] [Abstract] [Full Text] [Related]
2. Is YKL-40 a new therapeutic target in cancer?
Johansen JS; Jensen BV; Roslind A; Price PA
Expert Opin Ther Targets; 2007 Feb; 11(2):219-34. PubMed ID: 17227236
[TBL] [Abstract] [Full Text] [Related]
3. Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival.
Wiseman SM; Makretsov N; Nielsen TO; Gilks B; Yorida E; Cheang M; Turbin D; Gelmon K; Huntsman DG
Cancer; 2005 May; 103(9):1770-7. PubMed ID: 15770691
[TBL] [Abstract] [Full Text] [Related]